inosine-diphosphate and Arteriosclerosis-Obliterans

inosine-diphosphate has been researched along with Arteriosclerosis-Obliterans* in 1 studies

Other Studies

1 other study(ies) available for inosine-diphosphate and Arteriosclerosis-Obliterans

Article	Year
[The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. Vestnik khirurgii imeni I. I. Grekova, 2011, Volume: 170, Issue:1 Results of conservative treatment of 31 patients with PAD are presented. In 3 and 6 months after 10 everyday intravenous infusions of Cytoflavin (combination of succinic acid, inosine, nicitinamide and riboflavin) average increase of painfree walking distance among nonsmokers was 50.6% and 64.4% vs. 108.0% and 170.5% in subgroup of smokers respectively. Average increase of maximal walking distance in subgroup of nonsmoking and smoking patients was respectively 30.1% and 130.5% in three months and 37.6% and 144.8% in 6 months after Cytoflavin infusions. Topics: Aged; Arteriosclerosis Obliterans; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Infusions, Intravenous; Inosine Diphosphate; Leg; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome; Walking	2011

Article

Year

[The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].

Vestnik khirurgii imeni I. I. Grekova, 2011, Volume: 170, Issue:1

Results of conservative treatment of 31 patients with PAD are presented. In 3 and 6 months after 10 everyday intravenous infusions of Cytoflavin (combination of succinic acid, inosine, nicitinamide and riboflavin) average increase of painfree walking distance among nonsmokers was 50.6% and 64.4% vs. 108.0% and 170.5% in subgroup of smokers respectively. Average increase of maximal walking distance in subgroup of nonsmoking and smoking patients was respectively 30.1% and 130.5% in three months and 37.6% and 144.8% in 6 months after Cytoflavin infusions.

Topics: Aged; Arteriosclerosis Obliterans; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Infusions, Intravenous; Inosine Diphosphate; Leg; Male; Middle Aged; Niacinamide; Succinates; Treatment Outcome; Walking

2011